NCT05889143View on ClinicalTrials.gov

A Study to Evaluate the Efficacy and Safety of CREZET Tablet

Active, not recruitingOBSERVATIONAL
Enrollment

15,000

Participants

Timeline

Start Date

May 24, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

March 1, 2026

Conditions
Dyslipidemias
Interventions
DRUG

Ezetimibe/Rosuvastatin

Patient treated with Crezet Tablet

Trial Locations (1)

Unknown

Kimyounggi Clinic, Busan

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY